Adherex Technologies Inc. (FENC) Posts Quarterly Earnings Results
Adherex Technologies Inc. (NASDAQ:FENC) posted its earnings results on Monday. The company reported ($0.15) EPS for the quarter, RTT News reports. During the same quarter in the prior year, the company earned ($0.04) earnings per share.
Adherex Technologies (NASDAQ:FENC) traded up $0.20 on Tuesday, reaching $10.18. The company’s stock had a trading volume of 5,600 shares, compared to its average volume of 39,021. Adherex Technologies has a 12-month low of $8.00 and a 12-month high of $13.95.
About Adherex Technologies
Fennec Pharmaceuticals Inc, formerly Adherex Technologies Inc, is a biopharmaceutical company focused on cancer therapeutics. The Company’s lead product candidate in the clinical stage of development includes Sodium Thiosulfate (STS), which has completed patient enrollment of over two Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children.
Receive News & Ratings for Adherex Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adherex Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.